![Arie Belldegrun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 36 M $ al 31/08/2026
Arie S. Belldegrun es un emprendedor y empresario que fundó 6 empresas, entre ellas Kite Pharma, Inc., Allogene Therapeutics, Inc. y Agensys, Inc. y que ha estado al frente de 16 empresas diferentes. En la actualidad, ocupa el cargo de presidente y socio de Two River Group Holdings LLC, presidente de Two River Group Management LLC, presidente de Bellco Capital LLC (que fundó en 2003), presidente de Two Rivers Consulting Corp, presidente de UroGen Pharma Ltd., presidente y socio de Two River Consulting LLC, presidente ejecutivo de Allogene Therapeutics, Inc. (que fundó en 2017), presidente de Kronos Bio, Inc, copresidente de Breakthrough Properties LLC, director general sénior de VV Manager LLC (que fundó en 2017), director general sénior de Vida Ventures LLC (que fundó en 2017) (una filial de VV Manager LLC) y presidente de Technology Assessment Group. Arie S. Belldegrun también es director y profesor del Instituto de Oncología Urológica de la UCLA, jefe de la División de Oncología Urológica de la Facultad de Medicina David Geffen y director general sénior de Vida Ventures LLC (que fundó en 2017) y forma parte del consejo de administración de otras 5 empresas. El Dr. Belldegrun fue anteriormente presidente de Arno Therapeutics, Inc. y presidente no ejecutivo en Arno Therapeutics, Inc. (una filial de Arno Therapeutics, Inc.), presidente y director general de Equinor ASA, director de Agensys, Inc. (fundó la empresa en 1997), Presidente Ejecutivo, Presidente y Director General de Kite Pharma, Inc. (fundó la empresa en 2009), presidente del Comité de Tecnología Biológica Molecular de la American Urological Association Education & Research, Inc., investigador del Instituto Nacional del Cáncer y miembro del Comité de Economía y Empleo de Los Ángeles. Arie S. Belldegrun se doctoró en la Facultad de Medicina de la Universidad Hebrea Hadassah y se graduó en el Instituto de Ciencias Weizmann.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2026 | 9.060.187 ( 2,62 % ) | 18 M $ | 31/08/2026 | |
UROGEN PHARMA LTD. 0,84 % | 22/06/2026 | 408.693 ( 0,84 % ) | 18 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| UROGEN PHARMA LTD. | Presidente | 01/10/2012 |
| ALLOGENE THERAPEUTICS, INC. | Fundador | 01/11/2017 |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Director/Miembro de la Junta | - |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC is an active manager. | Presidente | 01/06/2018 |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Fundador | 01/01/2017 |
ByHeart, Inc.
 ByHeart, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Develops nutrition infant formula products based on breast milk | Director/Miembro de la Junta | 01/10/2019 |
105 W First Street LLC
 105 W First Street LLC Real Estate Investment TrustsFinance Provides real estate investment trusts and financial services | Director/Miembro de la Junta | - |
Bellco Capital LLC
 Bellco Capital LLC Investment ManagersFinance Bello Capital invests in companies located in the United States. The firm targets companies operating in the life science, real estate, consumer products, and media sectors. It provides financing for later stage capital requirements. | Fundador | 01/01/2004 |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2000 |
| ░░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 43 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Email Real Estate.com, Inc.
 Email Real Estate.com, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Equinor ASA
 Equinor ASA Integrated OilEnergy Minerals Engages in production, exploration and marketing of oil & natural gas and generates wind power | Energy Minerals |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group invests in companies located in the United States. The firm focuses on life sciences and healthcare sectors. It participates in early stage capital requirements. | Finance |
Paramount Acquisition Corp.
 Paramount Acquisition Corp. Financial ConglomeratesFinance Investment vehicle acquiring operating businesses in the healthcare industry | Finance |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Arno Therapeutics, Inc. /Old/
 Arno Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical to treat cancer | Health Technology |
Technology Assessment Group
 Technology Assessment Group Miscellaneous Commercial ServicesCommercial Services Provides research and evaluation services for the effects of drug therapies | Commercial Services |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines for cancers | Commercial Services |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Urological Association Education & Research, Inc.
 American Urological Association Education & Research, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a urologic association | Commercial Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Los Angeles Economy & Jobs Committee | |
Sonablate Corp.
 Sonablate Corp. Medical SpecialtiesHealth Technology Develops and manufactures high intensity focused ultrasound surgical ablation systems | Health Technology |
Arno Therapeutics, Inc.
 Arno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs | Health Technology |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Bioscience for the State of California | |
Bellco Capital LLC
Bellco Capital LLC Investment ManagersFinance Bello Capital invests in companies located in the United States. The firm targets companies operating in the life science, real estate, consumer products, and media sectors. It provides financing for later stage capital requirements. | Finance |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
UCLA Institute of Urologic Oncology | |
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
The Hebrew University Hadassah Medical School
 The Hebrew University Hadassah Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The American Association of Genitourinary Surgeons
 The American Association of Genitourinary Surgeons Miscellaneous Commercial ServicesCommercial Services Operates as an urologist association | Commercial Services |
Ginkgo Bioworks, Inc.
 Ginkgo Bioworks, Inc. Miscellaneous Commercial ServicesCommercial Services Builds autonomous labs to accelerate R&D in biotechnology | Commercial Services |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Develops disruptive cell-based therapies for cancer and other devastating diseases | Health Technology |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Health Technology |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research | Commercial Services |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
ByHeart, Inc.
ByHeart, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Develops nutrition infant formula products based on breast milk | Consumer Non-Durables |
105 W First Street LLC
105 W First Street LLC Real Estate Investment TrustsFinance Provides real estate investment trusts and financial services | Finance |
Breakthrough Properties LLC
Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC is an active manager. | Finance |
Breakthrough Services LLC
 Breakthrough Services LLC Breakthrough Services LLC is an assisted living facility. The company is based in New York. | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Health Technology |
Soaring Eagle Acquisition Corp.
 Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
 Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Functions as investment fund | Finance |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology Develops transformational therapies for patients with life-threatening disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
